Article Sidebar

download PDF
 Open Access
Published:
Aug 19, 2013

Article Details

Issue
Vol. 17 No. 3 (2013)
Section
Articles

The author(s) retain copyright on work published by AOSIS unless specified otherwise.

Licensing and publishing rights

Author(s) of work published by AOSIS are required to grant AOSIS the unlimited rights to publish the definitive work in any format, language and medium, for any lawful purpose. AOSIS requires journal authors to publish their work in open access under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. 

Read more here: http://creativecommons.org/licenses/by/4.0/.

The authors retain the non-exclusive right to do anything they wish with the published article(s), provided attribution is given to the applicable journal with details of the original publication, as set out in the official citation of the article published in the journal. The retained right specifically includes the right to post the article on the authors’ or their institution’s websites or in institutional repositories.

Previously published work may have been published under a different licence. We advise the community that if they would like to reuse the work to consult the applicable licence at article level.

Main Article Content

Nephrogenic systemic fibrosis (NSF) and gadolinium-based contrast media


PS Ngoya
Z Vawda
JW Lotz

Abstract

Nephrogenic systemic fibrosis (NSF), unknown before March 1997 and first described in 2000, is a systemic disorder characterised by widespread tissue fibrosis. The first known case occurred in 1997, after the use of  gadolinium-based contrast agents (GBCAs) at high doses in patients with renal failure had become routine. An overwhelming majority occurred within weeks to months after injection of a GBCA. The link between nephrogenic
systemic fibrosis (NSF) and GBCAs was recognised in 2006. This note  comprises guidelines on the prevention of NSF.